In parallel $ALST intends to appoint new Board Members with strong experience in Clinical Development, Sales & Marketing, Distribution and Nutrition.
"We have entered into discussions with several key acquisition candidates and expect to close on these negotiations over the next quarter. Some of these initiatives include revenue-producing companies, and novel products, quoted Dr. Daniel Bagi CEO of AllStar. "Further additions to our Board and Management will be revealed as well in the short-term".
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.